Aethlon Medical, Inc.

  • Home
  • The Hemopurifier®
    • The Hemopurifier® in Infectious Disease
    • The Hemopurifier® in Cancer
    • Resources
  • About
    • Overview
    • Exosome Sciences, Inc.
    • Executive Team
    • Board of Directors
    • Scientific Advisory Board
    • Contact Us
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • Outside Media
  • Investors
    • Overview
    • Corporate News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
    • IRS Form 8937
News & Media

News & Media

  • Press Releases
  • Presentations
  • Events
  • Outside Media

Press Releases

Feb 4, 2021

Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 10, 2021

Jan 6, 2021

Aethlon Medical Expands Leadership Team with Appointment of Chief Business Officer and Chief Medical Officer

Jan 4, 2021

Aethlon Medical to Present at the H.C. Wainwright BioConnect 2021 Conference

Dec 16, 2020

Aethlon Medical Announces First Patient Treated in First-in-Human Clinical Trial of HEMOPURIFIER® in Head and Neck Cancer

Nov 3, 2020

Aethlon Announces Appointment of Charles J. Fisher, Jr., M.D. as Chief Executive Officer

Oct 28, 2020

Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update

Oct 19, 2020

Aethlon Medical To Release Second Quarter Financial Results and Host Conference Call on October 28, 2020

Sep 9, 2020

Aethlon Medical to Present at the H.C. Wainwright 22nd Annual Global Investment Conference

Aug 27, 2020

Aethlon Medical to Present at the LD Micro 500 Virtual Conference

Aug 11, 2020

Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update

    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...20
    • Twitter
    • Linkedin
    • YouTube
    Privacy Policy Disclaimer Sitemap
    © 2022 Aethlon Medical, Inc. All Rights Reserved.